Simvastatin and Neoplasm malignant - a phase IV clinical study of FDA data
Summary:
Neoplasm malignant is reported as a side effect among people who take Simvastatin (simvastatin), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Aspirin, and have Metastases to bone.
The phase IV clinical study analyzes which people have Neoplasm malignant when taking Simvastatin. It is created by eHealthMe based on reports of 249,370 people who have side effects when taking Simvastatin from the FDA, and is updated regularly.
What is Simvastatin?
Simvastatin has active ingredients of simvastatin. It is often used in high blood cholesterol. eHealthMe is studying from 256,970 Simvastatin users. Check the latest studies of Simvastatin.
What is Neoplasm malignant?
Neoplasm malignant (cancer tumour) is found to be associated with 1,540 drugs and 1,261 conditions by eHealthMe. Check the latest studies of Neoplasm malignant.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
249,370 people reported to have side effects when taking Simvastatin.
Among them, 712 people (0.29%) have Neoplasm malignant.
Among these 712 people:
How long have people been on Simvastatin when they have Neoplasm malignant? *
What is the gender of people who have Neoplasm malignant when taking Simvastatin? *
What is the age of people who have Neoplasm malignant when taking Simvastatin? *
What are other drugs people take besides Simvastatin? *
What are other side effects people have besides Neoplasm malignant? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Simvastatin and have Neoplasm malignant?
- Check whether Neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Simvastatin:
- Simvastatin (256,970 reports)
Neoplasm malignant treatments and more:
- Neoplasm malignant (105,565 reports)
How severe was Neoplasm malignant and when was it recovered:
Expand to all the drugs that have ingredients of simvastatin:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Simvastatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Neoplasm malignant:
- Neoplasm malignant (1,540 drugs)
Browse all the conditions that are associated with Neoplasm malignant:
- Neoplasm malignant (1,261 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on simvastatin (the active ingredients of Simvastatin) and Simvastatin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Tysabri and Muscle Rupture for Women aged 40-49 - a second ago
- Tysabri and Muscle Rupture for Women aged 50-59 - a second ago
- Could Peginterferon cause Suicidal Ideation? - 7 seconds ago
- Post Procedural Complication and drugs of ingredients of lisdexamfetamine dimesylate - 9 seconds ago
- Microalbuminuria and drugs of ingredients of gliclazide - 9 seconds ago
- Could Gengraf cause Syncope Aggravated? - 9 seconds ago
- Zemplar and Omniscan drug interactions for women aged 40-49 - 11 seconds ago
- Drowsiness and drugs of ingredients of naproxen - 15 seconds ago
- Could Tolterodine cause Delusion? - 15 seconds ago
- Abdominal Discomfort and drugs of ingredients of hyoscine butylbromide - 16 seconds ago